Vasoactive Drugs in Intensive Care Unit
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 836 participants.
Also called NCT02118467
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 836 participants
- Sponsor
- Registry
-
NCT02118467
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT02118467. Randomized; triple masking; primary purpose treatment. Start 2014-05-15 (actual); primary completion 2026-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vasoactive Drugs in Intensive Care Unit
- Condition
- Shock
- Intervention (Drug)
- Norepinephrine
- Intervention (Drug)
- Epinephrine
- Intervention (Drug)
- Phenylephrine
- Intervention (Drug)
- Vasopressin
- Lead sponsor
- University of Chicago
Record details
- Record id
cardio:ct-nct02118467- Content hash
29216bb2b69890d319486b213f8f2a1474288ace29b0d66660bfee8e115d8852